We are live on ! Find out more
NGNE icon

Neurogene

82 hedge funds and large institutions have $342M invested in Neurogene in 2021 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 23 increasing their positions, 33 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

2% more capital inflows, than outflows

Capital inflows: $20.1M | Capital outflows: $19.8M

0.47% less ownership

Funds ownership: 66.08% → 65.61% (-0.47%)

2% less funds holding

Funds holding: 84 → 82 (-2)

25% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 8

30% less repeat investments, than reductions

Existing positions increased: 23 | Existing positions reduced: 33

63% less call options, than puts

Call options by funds: $1M | Put options by funds: $2.7M

Holders
82
Holders Change
-2
Holders Change %
-2.38%
% of All Funds
1.43%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
23
Reduced
33
Closed
8
Calls
$1M
Puts
$2.7M
Net Calls
-$1.7M
Net Calls Change
-$370K

NGNE Hedge Fund Activity: Q1 2021 in Review

82 of the 5,715 institutional investors tracked by Wall St. Rank reported a position in Neurogene (NGNE) for Q1 2021, worth a combined $342M — down 13% from $391M a quarter earlier.

Sellers outnumbered buyers: 8 funds closed out of NGNE and 6 opened new positions — a net loss of 2 holders — while 33 trimmed existing stakes and 23 added.

The largest buyer was State Street, adding an estimated $5.13M. The largest seller was Dimensional Fund Advisors, cutting an estimated $2.92M.

  • 82 institutional investors held Neurogene (NGNE) as of Q1 2021, down from 84 in Q4 2020.
  • Funds reported $342M of Neurogene stock for Q1 2021, down 13% quarter-over-quarter.
  • 6 funds opened new Neurogene positions in Q1 2021 and 8 closed out, a net change of -2 holders.
  • The largest Neurogene buyer in Q1 2021 was State Street, an estimated $5.13M added.
  • The largest Neurogene seller in Q1 2021 was Dimensional Fund Advisors, an estimated $2.92M sold.

Based on aggregated 13F filings for Q1 2021.